Current knowledge of ferroptosis in the pathogenesis and prognosis of oral squamous cell carcinoma | Canada Hyperbarics Skip to main content
Review Cell Signal 2024

Current knowledge of ferroptosis in the pathogenesis and prognosis of oral squamous cell carcinoma

Zhou L, Wu Y, Ying Y, Ding Y — Cell Signal, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reviewed existing studies to understand how ferroptosis, a specific type of cell death, affects oral squamous cell carcinoma (OSCC), a type of mouth cancer.

What They Found

They found that factors related to ferroptosis, including specific genes and the tumor environment, can predict the outcome for OSCC patients. The study also identified that OSCC growth might be linked to blocking ferroptosis, and several treatments, including hyperbaric oxygen therapy (HBOT), can trigger ferroptosis to kill OSCC cells.

What This Means for Canadian Patients

This research suggests that targeting ferroptosis could be a new way to treat oral squamous cell carcinoma, a type of mouth cancer. While HBOT is mentioned as one of several interventions that can induce ferroptosis in OSCC cells, more research is needed to determine its specific role and effectiveness in a clinical setting for Canadian patients with this condition.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This was a comprehensive review, meaning it summarized existing research rather than conducting new experiments or clinical trials.

Was this summary helpful?

Study Details

Study Type Review
Category Systematic Reviews
Source Pubmed
PubMed ID 38636767
Year Published 2024
Journal Cell Signal
MeSH Terms Ferroptosis; Humans; Mouth Neoplasms; Prognosis; Carcinoma, Squamous Cell; Gene Expression Regulation, Neoplastic; Tumor Microenvironment

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.